Non-Hodgkin′s lymphoma: Is India ready to incorporate recent advances in day to day practice

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 1, 2010, Pages 36-40

  Vallabhajosyula, Saraschandra ^a   Baijal, Gunjan ^a   Vadhiraja, B M ^a   Fernandes, Donald ^a   Vidyasagar, M S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

CHOP; Community health insurance; International classification of disease for oncology; Non Hodgkin s lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT; CEOP PROTOCOL 1; CHOP PROTOCOL; EPIRUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; IMVP 16 PROTOCOL; IMVP-16 PROTOCOL; METHOTREXATE; PREDNISONE; PRO MACE C MOPP PROTOCOL; PRO-MACE-C-MOPP PROTOCOL; PROCARBAZINE;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CLINICAL PRACTICE; FEMALE; FINANCIAL MANAGEMENT; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PROGNOSIS; WHOLE BODY CT; ATTITUDE TO HEALTH; DEVELOPING COUNTRY; ECONOMICS; HEALTH CARE DISPARITY; STATISTICS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DEVELOPING COUNTRIES; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; IFOSFAMIDE; INDIA; LEUCOVORIN; LYMPHOMA, NON-HODGKIN; METHOTREXATE; PATIENT COMPLIANCE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

EID: 77952604858     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.63571     Document Type: Article

References (12)

1. Zinzani PL. Lymphoma: diagnosis, staging, natural history, and treatment strategies. Semin Oncol2005;32: S4-10.
2. McLaughlin P, Fuller L, Redman J, Hagemeister F, Durr E, Allen P, et al. Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy. Ann Oncol 1991;2:137-40.
3. Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998;339:21-6.
4. Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997;336:1290-7.
5. Cerny T, Gillessen S. Advances in the treatment of non-Hodgkin's lymphoma. Ann Oncol 2002;13:211-6.
6. National Cancer Registry Programme: First All India Report 2001-2002: Available from: www.canceratlasindia.org/chapter6-report.asp. [cited on 2004].
7. Tilly H, Dreyling M; ESMO Guidelines Working Group. Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol2008;19: ii67-9.
8. Fisher RI. Overview of Non-Hodgkin's Lymphoma: biology, staging, and treatment. Semin Oncol 2003;30:3-9.
9. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-42.
10. Peters DH, Yazbeck AS, Sharma RR, Ramana GN, Pritchett LH, Wagstaff A. Better health systems for India's poor: Findings, analysis and options. Human Development Network (Health, nutrition, and population series). Washington DC: World Bank; 2002. p. 1-376.
11. Community Health Insurance in India - An Overview. In: Devadasan N, Ranson K, van Damme W, editors. Bart Criel: Economic and Political Weekly; 2004. p. 3179-83.
12. Atim C. Contribution of mutual health organizations to financing, delivery, and access to health care: Synthesis of research in nine west and central african countries. Bethesda, Maryland: Abt Associates Inc; 1998. p. 82.